Dhansa Labs Q2 Profit Rises 22% Despite Flat Sales Growth
Key highlights
- Dhansa Labs' standalone Q2 net profit rose 21.5% year on year to Rs 1.73 crore.
- Q2 revenue from operations was Rs 40.01 crore, up 0.3% from Rs 39.89 crore.
- First-half net profit increased 17.1% to Rs 3.07 crore while revenue rose 3.5% to Rs 70.58 crore.
- Dhansa Labs had utilised all Rs 21.62 crore received from convertible warrants by 30 September 2026.
powered by IRIS

Dhansa Labs Limited reported standalone net profit of Rs 1.73 crore for the quarter ended 30 September 2026, up 22% year on year, while revenue from operations increased 0.3% to Rs 40.01 crore. Lower inventory-change expense, finance cost and depreciation helped profit growth despite near-flat sales.
Know Dhansa Labs inside out
Results, valuation, peers and who's buying, in one view.
How did Dhansa Labs perform in the September 2026 quarter?
Dhansa Labs reported standalone net profit of Rs 1.73 crore for the quarter ended 30 September 2026, compared with Rs 1.42 crore in the corresponding quarter a year earlier. The increase was 21.5%, while basic and diluted earnings per share rose to Rs 0.65 from Rs 0.57. The standalone results are unaudited and were approved by the board on 14 November 2026.
Revenue from operations was Rs 40.01 crore, against Rs 39.89 crore in the quarter ended 30 September 2025. The increase of Rs 0.12 crore meant sales expanded by about 0.3%, substantially below the rise in net profit. Other income fell to Rs 2.90 lakh from Rs 11.32 lakh, indicating that the profit increase was recorded despite a lower contribution from this line.
Profit before tax increased to Rs 2.13 crore from Rs 1.67 crore in the September 2025 quarter. Tax expense was Rs 40.14 lakh, compared with Rs 24.22 lakh a year earlier, so the increase in net profit was smaller than the rise in pre-tax profit. No exceptional item was reported in either September quarter.
What changed in Dhansa Labs' quarterly costs?
Dhansa Labs' total expenses increased to Rs 37.91 crore in the September 2026 quarter from Rs 33.83 crore a year earlier, an increase of Rs 4.08 crore. Although expenses rose faster than revenue, the composition of costs changed: the inventory-change line declined by more than the increase in material consumption, while finance costs and depreciation also fell.
Material consumed, the largest stated expense, rose to Rs 33.78 crore from Rs 30.11 crore, an increase of Rs 3.67 crore. Changes in inventories of work-in-progress and finished goods were Rs 1.22 crore, compared with Rs 5.06 crore in the prior-year quarter. The Rs 3.84 crore reduction in this inventory-change expense was larger than the rise in material consumption.
Employee benefits expense decreased to Rs 41.15 lakh from Rs 46.63 lakh, while finance costs declined to Rs 51.15 lakh from Rs 92.44 lakh. Depreciation and amortisation fell to Rs 44.89 lakh from Rs 55.36 lakh, whereas other expenses rose slightly to Rs 1.24 crore from Rs 1.22 crore.
Sequentially, revenue from operations rose from Rs 30.56 crore in the quarter ended 30 June 2026 to Rs 40.01 crore in the September quarter. Net profit increased from Rs 1.34 crore to Rs 1.73 crore, although profit before tax was nearly unchanged at Rs 2.13 crore versus Rs 2.14 crore. Tax expense fell to Rs 40.14 lakh from Rs 80.08 lakh over the two quarters.
Got a follow-up? Ask IRIS
How did Dhansa Labs' first-half results compare with last year?
Dhansa Labs reported standalone net profit of Rs 3.07 crore for the half year ended 30 September 2026, up 17.1% from Rs 2.62 crore in the corresponding half year. Revenue from operations increased 3.5% to Rs 70.58 crore from Rs 68.18 crore, extending the pattern of profit growth exceeding sales growth.
Profit before tax for the six months rose to Rs 4.27 crore from Rs 3.01 crore in the half year ended 30 September 2025. Total expenses were Rs 66.97 crore, compared with Rs 65.30 crore, while total income was Rs 71.24 crore, compared with Rs 68.31 crore. The latest half-year tax expense was Rs 1.20 crore, versus Rs 38.40 lakh in the previous corresponding period.
The prior-year half-year tax calculation included a minimum alternate tax, or MAT, credit of Rs 56.52 lakh, which was not reported for the half year ended 30 September 2026. Current tax was Rs 88.35 lakh in the latest six months against Rs 56.52 lakh a year earlier, and deferred tax charge was Rs 31.86 lakh against Rs 38.40 lakh.
Against the immediately preceding half year ended 31 March 2026, revenue from operations of Rs 70.58 crore was lower than Rs 73.36 crore. Net profit of Rs 3.07 crore was also below Rs 3.11 crore in that preceding half year, while the year ended 31 March 2026 produced revenue from operations of Rs 141.54 crore and net profit of Rs 5.73 crore.
What funding and review disclosures accompanied Dhansa Labs' results?
Dhansa Labs said it allotted 1.09 crore convertible equity warrants during the year ended 31 March 2026 at an issue price of Rs 46 per warrant. The preferential issue had a total size of Rs 50.00 crore, of which the company had received Rs 21.62 crore as warrant subscription or part consideration by 30 September 2026.
The company reported that it had utilised the full Rs 21.62 crore received by 30 September 2026, leaving no unutilised amount. The disclosed uses were general corporate purposes, advances for plant and machinery, support for ongoing capital expenditure and land-related advances. The filing reported no deviation from these stated objects.
Kapish Jain & Associates reviewed the standalone results under Standard on Review Engagement 2410. The reviewer said nothing had come to its attention indicating that the statement failed to make required disclosures or contained a material misstatement. The report also states that a review is narrower in scope than an audit and does not provide an audit opinion.
Dhansa Labs also appointed K K Baranwal & Associates as internal auditor on 14 November 2026. The company said the appointment reflected the growing scale and complexity of its operations, including subsidiaries, and was intended to strengthen internal control, risk management and governance arrangements.
Conclusion
Dhansa Labs' September-quarter figures show a 22% rise in standalone net profit to Rs 1.73 crore despite revenue moving only 0.3% higher to Rs 40.01 crore. The result coincided with lower inventory-change expense, finance costs and depreciation, although total expenses increased to Rs 37.91 crore and material consumption rose to Rs 33.78 crore.
The next disclosures to watch are the progress of the ongoing capital expenditure and plant-and-machinery advances funded through Rs 21.62 crore of warrant proceeds, all of which had been utilised by 30 September 2026. Dhansa Labs' internal-audit appointment on 14 November 2026 is also linked by management to the expanding scale and complexity of its operations, including subsidiaries.


